Background. Overweight and obesity often develop in individuals with genetic susceptibility
and concomitant risk factors; however, medications can represent precipitating factors in …

Background The effects of β-blockers on metabolic parameters including weight loss are
poorly understood. Methods From a database of 3582 patients who completed The Ottawa …

Background: Sympathetic activation is an important metabolic adaptation limiting weight
gain. Propensity of weight gain associated with β-blocker therapy in the obese modern …

One of the arguments put forward against the primary use of β-blockers has been concern
about adverse metabolic effects, such as unfavorable effects on lipids or insulin sensitivity …

Beta‐blockers are the most frequently used drugs for the treatment of hypertension. Apart
from concerns regarding potential adverse metabolic effects on lipids or insulin sensitivity …

PURPOSE: Patients with type 2 diabetes are commonly overweight, which can contribute to
poor cardiovascular outcomes. β-blockers may promote weight gain, or hamper weight loss …

Catalase polymorphism May Influence the Pathogenesis of Diabetes Mellitus Page 1 *Corresponding
author email: annwyne.houldsworth@gmail.ac.uk. Symbiosis Group Symbiosis www.symbiosisonline.org …

Psychological aspects of dieting, including hunger and satiety sensations were explored in
obese subjects during a placebo-controlled trial of the weight reducing potential of BRL …

Background Although the pathophysiological mechanisms of arterial hypertension are
different in obese and lean patients, hypertension guidelines do not include specific …

Beta‐blockers are among the most widely used antihypertensive drugs. They differ from
each other in regard to several factors such as: β‐agonist activity, β1‐selectivity and …